Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Infected chronic ischemic wound topically treated with a multi-strain probiotic formulation: a novel tailored treatment strategy.

Venosi S, Ceccarelli G, de Angelis M, Laghi L, Bianchi L, Martinelli O, Maruca D, Cavallari EN, Toscanella F, Vassalini P, Trinchieri V, Oliva A, d'Ettorre G.

J Transl Med. 2019 Nov 9;17(1):364. doi: 10.1186/s12967-019-2111-0.

2.

Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients.

Landi C, Santinelli L, Bianchi L, Shaba E, Ceccarelli G, Cavallari EN, Borrazzo C, Pinacchio C, Scagnolari C, Vullo V, Bini L, d'Ettorre G.

J Neurovirol. 2019 Nov 1. doi: 10.1007/s13365-019-00801-7. [Epub ahead of print]

PMID:
31677067
3.

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study.

Ceccarelli G, Borrazzo C, Lazzaro A, Innocenti GP, Celani L, Cavallari EN, Pinacchio C, Santinelli L, Mastroianni CM, d'Ettorre G.

Brain Sci. 2019 Oct 17;9(10). pii: E278. doi: 10.3390/brainsci9100278.

4.

Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation.

Falasca F, Cavallari EN, Innocenti GP, Scagnolari C, Mezzaroma I, Santinelli L, Ceccarelli G, Vullo V, Turriziani O, d'Ettorre G.

Curr HIV Res. 2019;17(3):183-189. doi: 10.2174/1570162X17666190903230622.

PMID:
31490760
5.

Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.

Ceccarelli G, Statzu M, Santinelli L, Pinacchio C, Bitossi C, Cavallari EN, Vullo V, Scagnolari C, d'Ettorre G.

Expert Opin Biol Ther. 2019 Sep;19(9):949-965. doi: 10.1080/14712598.2019.1638907. Epub 2019 Jul 10.

PMID:
31260331
6.

Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects.

De Angelis M, Scagnolari C, Oliva A, Cavallari EN, Celani L, Santinelli L, Innocenti GP, Borrazzo C, Ceccarelli G, Vullo V, d'Ettorre G.

Microorganisms. 2019 Jun 3;7(6). pii: E162. doi: 10.3390/microorganisms7060162.

7.

Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation.

Ceccarelli G, Pinacchio C, Santinelli L, Adami PE, Borrazzo C, Cavallari EN, Vullo A, Innocenti GP, Mezzaroma I, Mastroianni CM, d'Ettorre G.

AIDS Behav. 2019 Apr 23. doi: 10.1007/s10461-019-02510-y. [Epub ahead of print]

PMID:
31016505
8.

Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: A case report.

Ceccarelli G, Cavallari EN, Savinelli S, Bianchi L, Pierangeli A, Vullo F, Ciardi A, D'ettorre G.

Medicine (Baltimore). 2018 Apr;97(16):e0329. doi: 10.1097/MD.0000000000010329.

9.

Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.

Najafi Fard S, Schietroma I, Corano Scheri G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo G, Ceccarelli G, Scagnolari C, Vullo V, d'Ettorre G.

Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):319-329. doi: 10.1016/j.clinre.2017.11.006. Epub 2017 Dec 24.

PMID:
29279268
10.

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.

Ceccarelli G, Brenchley JM, Cavallari EN, Scheri GC, Fratino M, Pinacchio C, Schietroma I, Fard SN, Scagnolari C, Mezzaroma I, Vullo V, d'Ettorre G.

Nutrients. 2017 Nov 21;9(11). pii: E1269. doi: 10.3390/nu9111269.

11.

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.

Scheri GC, Fard SN, Schietroma I, Mastrangelo A, Pinacchio C, Giustini N, Serafino S, De Girolamo G, Cavallari EN, Statzu M, Laghi L, Vullo A, Ceccarelli G, Vullo V, d'Ettorre G.

Int J Tryptophan Res. 2017 May 30;10:1178646917710668. doi: 10.1177/1178646917710668. eCollection 2017.

12.

Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.

d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.

J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20.

PMID:
26765625
13.

An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report.

Serafino S, Cella E, Montagna C, Cavallari EN, Vittozzi P, Lo Presti A, Giovanetti M, Mazzuti L, Turriziani O, Ceccarelli G, d'Ettorre G, Vullo V, Ciccozzi M.

J Med Case Rep. 2015 Nov 3;9:253. doi: 10.1186/s13256-015-0717-2.

14.

Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.

d'Ettorre G, Baroncelli S, Micci L, Ceccarelli G, Andreotti M, Sharma P, Fanello G, Fiocca F, Cavallari EN, Giustini N, Mallano A, Galluzzo CM, Vella S, Mastroianni CM, Silvestri G, Paiardini M, Vullo V.

PLoS One. 2014 Oct 23;9(10):e109791. doi: 10.1371/journal.pone.0109791. eCollection 2014.

15.

Guillain Barre syndrome in an HIV-1-infected patient after the beginning of combined antiretroviral therapy: an immune reconstitution inflammatory syndrome?

Fantauzzi A, Digiulio MA, Cavallari EN, d'Ettorre G, Vullo V, Mezzaroma I.

New Microbiol. 2014 Jan;37(1):103-7. Epub 2014 Jan 15.

Supplemental Content

Loading ...
Support Center